These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22272726)

  • 1. Cellular prion and its catabolites in the brain: production and function.
    Guillot-Sestier MV; Checler F
    Curr Mol Med; 2012 Mar; 12(3):304-15. PubMed ID: 22272726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Secretase-derived cleavage of cellular prion yields biologically active catabolites with distinct functions.
    Guillot-Sestier MV; Checler F
    Neurodegener Dis; 2012; 10(1-4):294-7. PubMed ID: 22261541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-Dependent transcriptional control of cellular prion by presenilins.
    Vincent B; Sunyach C; Orzechowski HD; St George-Hyslop P; Checler F
    J Neurosci; 2009 May; 29(20):6752-60. PubMed ID: 19458243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
    Caughey B; Caughey WS; Kocisko DA; Lee KS; Silveira JR; Morrey JD
    Acc Chem Res; 2006 Sep; 39(9):646-53. PubMed ID: 16981681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion: toxic or infectious agent?
    Rico A
    Med Hypotheses; 2003 Feb; 60(2):209-14. PubMed ID: 12606237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
    Nandi PK; Nicole JC
    J Mol Biol; 2004 Nov; 344(3):827-37. PubMed ID: 15533448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural localization of prion proteins: physiological and pathological implications.
    Fournier JG; Escaig-Haye F; Grigoriev V
    Microsc Res Tech; 2000 Jul; 50(1):76-88. PubMed ID: 10871551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
    Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical Characterization of Prions.
    Fiorini M; Bongianni M; Monaco S; Zanusso G
    Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.
    Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T
    OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical analysis of the implication of PrP in neuronal death during transmissible subacute spongiform encephalopathies: hypothesis of a PrP oligomeric channel.
    Chapron Y; Peyrin JM; Crouzy S; Jaegly A; Dormont D
    J Theor Biol; 2000 May; 204(1):103-11. PubMed ID: 10772851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amphotericin B on wild-type and mutated prion proteins in cultured cells: putative mechanism of action in transmissible spongiform encephalopathies.
    Mangé A; Milhavet O; McMahon HE; Casanova D; Lehmann S
    J Neurochem; 2000 Feb; 74(2):754-62. PubMed ID: 10646527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion disease: a deadly disease for protein misfolding.
    Chakraborty C; Nandi S; Jana S
    Curr Pharm Biotechnol; 2005 Apr; 6(2):167-77. PubMed ID: 15853695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scrapie-associated PrP accumulation and its inhibition: revisiting the amyloid-glycosaminoglycan connection.
    Caughey B; Race RE
    Ann N Y Acad Sci; 1994 Jun; 724():290-5. PubMed ID: 8030949
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission and Replication of Prions.
    Marín-Moreno A; Fernández-Borges N; Espinosa JC; Andréoletti O; Torres JM
    Prog Mol Biol Transl Sci; 2017; 150():181-201. PubMed ID: 28838661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of neurotoxicity of pathological prion protein.
    Castilla J; Hetz C; Soto C
    Curr Mol Med; 2004 Jun; 4(4):397-403. PubMed ID: 15354870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.